Genmab — April 2014
-
lad mig bringe en af akademikerens mest udødelige guldkorn. I en diskussion om hvorvidt "markedet altid har ret" fremførte han...
-
"markedet har aldrig ret - ellers ville kurserne aldrig ændre sig"
-
Hende Rachel er dælme hurtig på tasterne - "I have not been informed of a new date for readout of this trial, although I do know the Phase 3s are all event driven, so timing can be affected if there are longer to events (which may be potentially a good thing). However, should I get an update we will update our investor communication accordingly"
-
...men et helt års udsættelse - det stemmer ikke helt med den pfs, der ellers er i de nuværede cll behandliger...
-
US biotek slutter i solidt plus - der er en mulighed for at vi ikke liber slaget i morgen
-
øøøh - får prygl i morgen
-
sandsynligheden taler for det - men det må vel for pokker vende på et tidspunkt
-
efterhånden har jeg svært ved at få værdisætningen af GEN til at hænge sammen - men det er selvfølgelig basret på en evt. godkendelse af ofa...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind